Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting

William N. Southern, M. L. Drainoni, B. D. Smith, C. L. Christiansen, Melissa D. McKee, A. L. Gifford, C. M. Weinbaum, D. Thompson, E. Koppelman, S. Maher, A. H. Litwin

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Approximately 3.2 million persons are chronically infected with the hepatitis C virus (HCV) in the U.S.; most are not aware of their infection. Our objectives were to examine HCV testing practices to determine which patient characteristics are associated with HCV testing and positivity, and to estimate the prevalence of HCV infection in a high-risk urban population. The study subjects were all patients included in the baseline phase of the Hepatitis C Assessment and Testing Project (HepCAT), a serial cross-sectional study of HCV screening strategies. We examined all patients with a clinic visit to Montefiore Medical Center from 1/1/08 to 2/29/08. Demographic information, laboratory data and ICD-9 diagnostic codes from 3/1/97-2/29/08 were extracted from the electronic medical record. Risk factors for HCV were defined based on birth date, ICD-9 codes and laboratory data. The prevalence of HCV infection was estimated assuming that untested subjects would test positive at the same rate as tested subjects, based on risk-factors. Of 9579 subjects examined, 3803 (39.7%) had been tested for HCV and 438 (11.5%) were positive. The overall prevalence of HCV infection was estimated to be 7.7%. Risk factors associated with being tested and anti-HCV positivity included: born in the high-prevalence birth-cohort (1945-64), substance abuse, HIV infection, alcohol abuse, diagnosis of cirrhosis, end-stage renal disease, and alanine transaminase elevation. In a high-risk urban population, a significant proportion of patients were tested for HCV and the prevalence of HCV infection was high. Physicians appear to use a risk-based screening strategy to identify HCV infection.

Original languageEnglish (US)
Pages (from-to)474-481
Number of pages8
JournalJournal of Viral Hepatitis
Volume18
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Hepatitis C
Ambulatory Care
Hepacivirus
Virus Diseases
International Classification of Diseases
Urban Population
Parturition
Electronic Health Records
Alanine Transaminase
Alcoholism
Chronic Kidney Failure
HIV Infections
Substance-Related Disorders
Fibrosis
Cross-Sectional Studies
Demography

Keywords

  • hepatitis C
  • prevalence
  • screening

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases
  • Virology

Cite this

Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. / Southern, William N.; Drainoni, M. L.; Smith, B. D.; Christiansen, C. L.; McKee, Melissa D.; Gifford, A. L.; Weinbaum, C. M.; Thompson, D.; Koppelman, E.; Maher, S.; Litwin, A. H.

In: Journal of Viral Hepatitis, Vol. 18, No. 7, 07.2011, p. 474-481.

Research output: Contribution to journalArticle

Southern, WN, Drainoni, ML, Smith, BD, Christiansen, CL, McKee, MD, Gifford, AL, Weinbaum, CM, Thompson, D, Koppelman, E, Maher, S & Litwin, AH 2011, 'Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting', Journal of Viral Hepatitis, vol. 18, no. 7, pp. 474-481. https://doi.org/10.1111/j.1365-2893.2010.01327.x
Southern, William N. ; Drainoni, M. L. ; Smith, B. D. ; Christiansen, C. L. ; McKee, Melissa D. ; Gifford, A. L. ; Weinbaum, C. M. ; Thompson, D. ; Koppelman, E. ; Maher, S. ; Litwin, A. H. / Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. In: Journal of Viral Hepatitis. 2011 ; Vol. 18, No. 7. pp. 474-481.
@article{42819d97b095442cbfd70d59650c8158,
title = "Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting",
abstract = "Approximately 3.2 million persons are chronically infected with the hepatitis C virus (HCV) in the U.S.; most are not aware of their infection. Our objectives were to examine HCV testing practices to determine which patient characteristics are associated with HCV testing and positivity, and to estimate the prevalence of HCV infection in a high-risk urban population. The study subjects were all patients included in the baseline phase of the Hepatitis C Assessment and Testing Project (HepCAT), a serial cross-sectional study of HCV screening strategies. We examined all patients with a clinic visit to Montefiore Medical Center from 1/1/08 to 2/29/08. Demographic information, laboratory data and ICD-9 diagnostic codes from 3/1/97-2/29/08 were extracted from the electronic medical record. Risk factors for HCV were defined based on birth date, ICD-9 codes and laboratory data. The prevalence of HCV infection was estimated assuming that untested subjects would test positive at the same rate as tested subjects, based on risk-factors. Of 9579 subjects examined, 3803 (39.7{\%}) had been tested for HCV and 438 (11.5{\%}) were positive. The overall prevalence of HCV infection was estimated to be 7.7{\%}. Risk factors associated with being tested and anti-HCV positivity included: born in the high-prevalence birth-cohort (1945-64), substance abuse, HIV infection, alcohol abuse, diagnosis of cirrhosis, end-stage renal disease, and alanine transaminase elevation. In a high-risk urban population, a significant proportion of patients were tested for HCV and the prevalence of HCV infection was high. Physicians appear to use a risk-based screening strategy to identify HCV infection.",
keywords = "hepatitis C, prevalence, screening",
author = "Southern, {William N.} and Drainoni, {M. L.} and Smith, {B. D.} and Christiansen, {C. L.} and McKee, {Melissa D.} and Gifford, {A. L.} and Weinbaum, {C. M.} and D. Thompson and E. Koppelman and S. Maher and Litwin, {A. H.}",
year = "2011",
month = "7",
doi = "10.1111/j.1365-2893.2010.01327.x",
language = "English (US)",
volume = "18",
pages = "474--481",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting

AU - Southern, William N.

AU - Drainoni, M. L.

AU - Smith, B. D.

AU - Christiansen, C. L.

AU - McKee, Melissa D.

AU - Gifford, A. L.

AU - Weinbaum, C. M.

AU - Thompson, D.

AU - Koppelman, E.

AU - Maher, S.

AU - Litwin, A. H.

PY - 2011/7

Y1 - 2011/7

N2 - Approximately 3.2 million persons are chronically infected with the hepatitis C virus (HCV) in the U.S.; most are not aware of their infection. Our objectives were to examine HCV testing practices to determine which patient characteristics are associated with HCV testing and positivity, and to estimate the prevalence of HCV infection in a high-risk urban population. The study subjects were all patients included in the baseline phase of the Hepatitis C Assessment and Testing Project (HepCAT), a serial cross-sectional study of HCV screening strategies. We examined all patients with a clinic visit to Montefiore Medical Center from 1/1/08 to 2/29/08. Demographic information, laboratory data and ICD-9 diagnostic codes from 3/1/97-2/29/08 were extracted from the electronic medical record. Risk factors for HCV were defined based on birth date, ICD-9 codes and laboratory data. The prevalence of HCV infection was estimated assuming that untested subjects would test positive at the same rate as tested subjects, based on risk-factors. Of 9579 subjects examined, 3803 (39.7%) had been tested for HCV and 438 (11.5%) were positive. The overall prevalence of HCV infection was estimated to be 7.7%. Risk factors associated with being tested and anti-HCV positivity included: born in the high-prevalence birth-cohort (1945-64), substance abuse, HIV infection, alcohol abuse, diagnosis of cirrhosis, end-stage renal disease, and alanine transaminase elevation. In a high-risk urban population, a significant proportion of patients were tested for HCV and the prevalence of HCV infection was high. Physicians appear to use a risk-based screening strategy to identify HCV infection.

AB - Approximately 3.2 million persons are chronically infected with the hepatitis C virus (HCV) in the U.S.; most are not aware of their infection. Our objectives were to examine HCV testing practices to determine which patient characteristics are associated with HCV testing and positivity, and to estimate the prevalence of HCV infection in a high-risk urban population. The study subjects were all patients included in the baseline phase of the Hepatitis C Assessment and Testing Project (HepCAT), a serial cross-sectional study of HCV screening strategies. We examined all patients with a clinic visit to Montefiore Medical Center from 1/1/08 to 2/29/08. Demographic information, laboratory data and ICD-9 diagnostic codes from 3/1/97-2/29/08 were extracted from the electronic medical record. Risk factors for HCV were defined based on birth date, ICD-9 codes and laboratory data. The prevalence of HCV infection was estimated assuming that untested subjects would test positive at the same rate as tested subjects, based on risk-factors. Of 9579 subjects examined, 3803 (39.7%) had been tested for HCV and 438 (11.5%) were positive. The overall prevalence of HCV infection was estimated to be 7.7%. Risk factors associated with being tested and anti-HCV positivity included: born in the high-prevalence birth-cohort (1945-64), substance abuse, HIV infection, alcohol abuse, diagnosis of cirrhosis, end-stage renal disease, and alanine transaminase elevation. In a high-risk urban population, a significant proportion of patients were tested for HCV and the prevalence of HCV infection was high. Physicians appear to use a risk-based screening strategy to identify HCV infection.

KW - hepatitis C

KW - prevalence

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=79959622260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959622260&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2893.2010.01327.x

DO - 10.1111/j.1365-2893.2010.01327.x

M3 - Article

VL - 18

SP - 474

EP - 481

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 7

ER -